- Karen Bernstein, PhD, Co-Founder and Chairman, BioCentury Publications Inc
- Laurence Blumberg, MD, Founder and CEO, Syntimmune, Inc.
- Stephen Mon Wei Chang, PhD, Senior Vice President, Strategic Initiatives, The New York Stem Cell Foundation
- Ron Cohen, MD, President & CEO, Acorda Therapeutics, Inc.
- Barry Coller, MD, Vice President, Medical Affairs, Physician-in-Chief, The Rockefeller University
- Ellen B. Corenswet, Partner, Covington & Burling LLP
- Pamela Demain, MBA, Executive Director, Corporate Licensing, Merck & Co., Inc.
- Eric Elenko, PhD, Executive Vice President, PureTech Health
- Gerald Fischbach, MD, Scientific Director, Simons Foundation
- Allan Goldberg, President and CEO, Avacyn Pharmaceuticals
- Julia P. Gregory, Former CEO, ContraFect
- Michael Gutch, PhD, Executive Director – Corporate Development, AstraZeneca
- Kimberly Ha, Senior Director, FTI Consulting
- Cláudia Hirawat, Chair, International Circle of Ambassadors, EURORDIS,
- Nouhad T. Husseini, Vice President, Business Development, Regeneron Pharmaceuticals, Inc.
- Kenneth Kaushansky, MD, MACP, Senior Vice President, Health Sciences Dean, School of Medicine, Stony Brook University
- Yung S. Lie, PhD, Deputy Director and CSO, Damon Runyon Cancer Research Foundation
- Ginny Llobell, Senior Vice President, Defined Health
- Joel S. Marcus, Chairman, Chief Executive Officer & Founder, Alexandria Real Estate Equities, Inc/ Alexandria Venture Investments
- Ronald Newbold, PhD, Vice President, External Research and Devlopment, Pfizer
- Timothy J. Pelura, PhD, President and CEO, Surpass, Inc.
- Glenn D. Prestwich, PhD, Presidential Professor, Medicinal Chemistry, University of Utah
- Linda M. Pullan, PhD, Principal, Pullan Consulting
- Barbara Ryan, Founder, Barbara Ryan Advisors
- Charles S. Ryan, JD, PhD, Vice President, General Counsel, Cold Spring Harbor Laboratory
- Todd Sherer, PhD, Chief Executive Officer, The Michael J. Fox Foundation for Parkinson’s Research (MJFF)
- Mark J. Simon, Advisor, Torreya Partners
- Barbara S. Slusher, PhD, MAS, Direcort, Johns Hopkins Drug Discovery
- Mary C. Tanner, Managing Director, Burrill & Company
October 8-9, 2024 - NYC
Alexandria Center for Life Science